NL8100259A - Combinaties van ketonen met heterocyclische verbindingen, famaceutische preparaten welke deze bevatten, werkwijze om dergelijke preparaten te bereiden en toepassing daarvan in de geneeskunde. - Google Patents

Combinaties van ketonen met heterocyclische verbindingen, famaceutische preparaten welke deze bevatten, werkwijze om dergelijke preparaten te bereiden en toepassing daarvan in de geneeskunde. Download PDF

Info

Publication number
NL8100259A
NL8100259A NL8100259A NL8100259A NL8100259A NL 8100259 A NL8100259 A NL 8100259A NL 8100259 A NL8100259 A NL 8100259A NL 8100259 A NL8100259 A NL 8100259A NL 8100259 A NL8100259 A NL 8100259A
Authority
NL
Netherlands
Prior art keywords
propiophenone
preparation according
diazepam
chloro
hydrochloride
Prior art date
Application number
NL8100259A
Other languages
English (en)
Dutch (nl)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NL8100259A publication Critical patent/NL8100259A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8100259A 1980-01-21 1981-01-20 Combinaties van ketonen met heterocyclische verbindingen, famaceutische preparaten welke deze bevatten, werkwijze om dergelijke preparaten te bereiden en toepassing daarvan in de geneeskunde. NL8100259A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8001910 1980-01-21
GB8001910 1980-01-21

Publications (1)

Publication Number Publication Date
NL8100259A true NL8100259A (nl) 1981-08-17

Family

ID=10510765

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8100259A NL8100259A (nl) 1980-01-21 1981-01-20 Combinaties van ketonen met heterocyclische verbindingen, famaceutische preparaten welke deze bevatten, werkwijze om dergelijke preparaten te bereiden en toepassing daarvan in de geneeskunde.

Country Status (13)

Country Link
US (2) US4571395A (fr)
JP (1) JPS56104819A (fr)
AU (1) AU552261B2 (fr)
BE (1) BE887151A (fr)
CA (1) CA1166157A (fr)
CH (1) CH647150A5 (fr)
DE (1) DE3101644A1 (fr)
FR (1) FR2473884B1 (fr)
IT (1) IT1142259B (fr)
NL (1) NL8100259A (fr)
NZ (1) NZ196048A (fr)
SE (1) SE8100276L (fr)
ZA (1) ZA81380B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE33994E (en) * 1983-08-16 1992-07-14 Burroughs Wellcome Co. Pharmaceutical delivery system
EP0199303B1 (fr) * 1985-04-18 1992-06-24 Oki Electric Industry Company, Limited Procédé pour obtenir des structures formant un agent de photoréserve
US5206238A (en) * 1990-11-13 1993-04-27 Merck & Co., Inc. Cholecystokinin antagonists
GB9217295D0 (en) * 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
GB9315856D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5358970A (en) * 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
US5541231A (en) * 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
US7098206B2 (en) * 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6998400B2 (en) * 1998-01-22 2006-02-14 Smithkline Beecham Corporation Pharmaceutically active morpholinol
CA2318921A1 (fr) 1998-01-29 1999-08-05 John R. Mccullough Usages pharmacologiques de (+)-bupropion optiquement pur
US6110973A (en) * 1998-01-29 2000-08-29 Sepracor Methods for treating obesity and weight gain using optically pure (-)-bupropion
US6734213B2 (en) 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6855820B2 (en) * 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US8545880B2 (en) * 1999-02-26 2013-10-01 Andrx Pharmaceuticals, Llc Controlled release oral dosage form
US6210716B1 (en) 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
US6337328B1 (en) * 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
US6342496B1 (en) 1999-03-01 2002-01-29 Sepracor Inc. Bupropion metabolites and methods of use
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US6893660B2 (en) * 2002-11-21 2005-05-17 Andrx Pharmaceuticals, Inc. Stable pharmaceutical compositions without a stabilizer
US20080207593A1 (en) * 2007-02-28 2008-08-28 Collegium Pharmaceutical, Inc. Antihistamine Combination
US8999393B1 (en) * 2013-01-09 2015-04-07 Edgemont Pharmaceuticals Llc Sustained release formulations of lorazepam
WO2022082058A1 (fr) * 2020-10-16 2022-04-21 Eleusis Therapeutics Us, Inc. Méthode de traitement par alcaloïdes tryptamines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA665638A (en) * 1963-06-25 L. Bolling Charles Ataractic compositions
FR2817M (fr) * 1962-07-02 1964-09-28 Merck & Co Inc Associations de médicaments pour le traitement des désordres mentaux.
NL136835C (fr) * 1965-12-03
GB1340032A (en) * 1969-12-04 1973-12-05 Wellcome Found Biologically active ketones
BE793775A (fr) * 1972-01-10 1973-07-09 Hoffmann La Roche Procede pour la stabilisation de comprimes pharmaceutiques
US4017619A (en) * 1973-10-26 1977-04-12 Burnap Raymond W Anesthetic and sedative composition

Also Published As

Publication number Publication date
CA1166157A (fr) 1984-04-24
DE3101644A1 (de) 1981-12-03
AU552261B2 (en) 1986-05-29
US4798826A (en) 1989-01-17
IT8147598A0 (it) 1981-01-20
FR2473884A1 (fr) 1981-07-24
ZA81380B (en) 1982-08-25
SE8100276L (sv) 1981-07-22
IT1142259B (it) 1986-10-08
US4571395A (en) 1986-02-18
NZ196048A (en) 1984-07-31
FR2473884B1 (fr) 1985-06-07
CH647150A5 (de) 1985-01-15
JPS56104819A (en) 1981-08-20
BE887151A (fr) 1981-07-20
AU6633681A (en) 1981-07-30

Similar Documents

Publication Publication Date Title
NL8100259A (nl) Combinaties van ketonen met heterocyclische verbindingen, famaceutische preparaten welke deze bevatten, werkwijze om dergelijke preparaten te bereiden en toepassing daarvan in de geneeskunde.
Amass et al. Alternate-day dosing during buprenorphine treatment of opioid dependence
US20160166648A1 (en) Treatment of Multiple Sclerosis With Combination of Laquinimod and Interferon-Beta
JP6196041B2 (ja) 大うつ病を有する患者において減量療法を提供する方法
EP0833651B1 (fr) Utilisation analgesique de n-l-alpha-aspartyl-l-phenylalanine 1-methyle ester
KR100712571B1 (ko) 코카인 중독증의 치료용 약제를 제조하기 위한플루마제닐의 용도
WO1989005642A1 (fr) Potentialisateur de dextrorphane pour compositions antispasmodiques et procedes
Glass et al. A comparison of dantrolene sodium and diazepam in the treatment of spasticity
Mancia et al. Comparison of angiotensin II receptor blockers: impact of missed doses of candesartan cilexetil and losartan in systemic hypertension
UA64725C2 (uk) Фармацевтична композиція ламівудину та зидовудину, спосіб її приготування (варіанти), комплект та спосіб пригнічення ретровірусної інфекції
NL8002041A (nl) Werkwijze voor het bereiden van een analgetisch en myotonolytisch geneesmiddel.
Citrome New antipsychotic medications: what advantages do they offer?
US20170007596A1 (en) Treatment of multiple sclerosis with combination of laquinimod and flupirtine
Ananth et al. Intramuscular lorazepam: A double-blind comparison with diazepam and placebo
JPH04342528A (ja) アルコール代謝およびアセトアルデヒド代謝促進剤
JP2004518699A (ja) クエチアピンを用いた物質乱用の治療方法
GB2067403A (en) Benzodiazepine compositions
KR880002523B1 (ko) 로라제팜의 부작용을 감소시키는 방법
Broncel et al. Bisoprolol in the treatment of hypertension in the elderly
Rosenberg Selective serotonin-reuptake inhibitors
Holtzman et al. Multicenter comparison of once‐and twice‐daily isradipine to hydrochlorothiazide for the treatment of hypertension in elderly patients
CA2917600A1 (fr) Traitement de la sclerose en plaques par induction a l'alemtuzumab suivie par une therapie par laquinimod
JP3172202B2 (ja) 不安の障害の処置剤
BOSCHERT Agents Compared for Preventing Stroke, CVD
Murasaki Overview of serotonin 1A receptor selective agents in anxiety disorders-the developmental situation in Japan

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed
A85 Still pending on 85-01-01
BV The patent application has lapsed